Thoracentesis
thoracentesis indications contraindications technique procedure
pleural fluid analysis Light's criteria exudate transudate
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 8084
thoracentesis procedure technique pleural effusion

Hugging Face pmc clinical VQA raw
Page 0
| Purpose | Examples |
|---|---|
| Diagnostic | New pleural effusion of unknown cause; suspected empyema, malignancy, or TB |
| Therapeutic | Symptomatic relief of large effusion causing dyspnea; drainage of empyema |
| Absolute | Relative |
|---|---|
| No safe access site | Coagulopathy (INR >1.5–2.0) / thrombocytopenia (<50,000) |
| — | Anticoagulation therapy |
| — | Small effusion (<1 cm on lateral decubitus / ultrasound) |
| — | Mechanical ventilation (increased pneumothorax risk) |
| — | Uncooperative patient |
There is no absolute INR threshold that precludes thoracentesis; risk-benefit assessment guides each case.

| Criterion | Exudate |
|---|---|
| Pleural fluid protein / serum protein | >0.5 |
| Pleural fluid LDH / serum LDH | >0.6 |
| Pleural fluid LDH | >2/3 upper limit of normal serum LDH |
| Transudate | Exudate |
|---|---|
| Left ventricular failure (most common in US) | Parapneumonic effusion / empyema |
| Cirrhosis (hepatic hydrothorax) | Malignancy |
| Nephrotic syndrome | Tuberculosis |
| Hypoalbuminemia | Pulmonary embolism |
| Constrictive pericarditis | Rheumatoid / autoimmune |
| Test | Interpretation |
|---|---|
| Cell count & differential | Neutrophils ↑ → parapneumonic; lymphocytes ↑ → TB, malignancy |
| Glucose | <60 mg/dL → empyema, rheumatoid, malignancy |
| pH | <7.2 → complicated parapneumonic (needs drainage) |
| Amylase | ↑ → esophageal rupture, pancreatitis |
| Triglycerides | >110 mg/dL → chylothorax |
| Cytology | Malignant cells |
| Culture & Gram stain | Infectious etiology |
| ADA (adenosine deaminase) | ↑ → TB (especially in high-prevalence settings) |
| Hematocrit | Hct fluid/Hct blood >0.5 → hemothorax |
| Complication | Notes |
|---|---|
| Pneumothorax | Most common (~6% without US, ~1% with US guidance) |
| Bleeding / hemothorax | Intercostal vessel laceration |
| Re-expansion pulmonary edema | Risk with large-volume drainage >1,500 mL |
| Infection / empyema | Poor sterile technique |
| Vasovagal reaction | Common; manage with positioning + IV fluids |
| Liver/spleen laceration | Incorrect needle position; prevented by US guidance |
| Subcutaneous emphysema | Rare |